Pharma IT Consulting Limited - Limited company - abbreviated - 11.6

Pharma IT Consulting Limited - Limited company - abbreviated - 11.6


08803781 5.12.13 31.12.14 31.12.14 Company accounts Private Limited Company FY true false true false false false true false Ordinary 1.00000 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure088037812013-12-04088037812014-12-31088037812013-12-052014-12-31088037812013-12-0408803781ns12:England2013-12-052014-12-3108803781ns14:PoundSterling2013-12-052014-12-3108803781ns7:Director12013-12-052014-12-3108803781ns7:OrdinaryShareClass12013-12-052014-12-3108803781ns7:RegisteredOffice2013-12-052014-12-3108803781ns7:EntityAccountantsOrAuditors2013-12-052014-12-3108803781ns5:ComputerEquipment2013-12-052014-12-3108803781ns7:OrdinaryShareClass12014-12-3108803781ns7:Director12013-12-0408803781ns7:Director12014-12-31
REGISTERED NUMBER: 08803781 (England and Wales)















ABBREVIATED UNAUDITED ACCOUNTS

FOR THE PERIOD 5 DECEMBER 2013 TO 31 DECEMBER 2014

FOR

PHARMA IT CONSULTING LIMITED

PHARMA IT CONSULTING LIMITED (REGISTERED NUMBER: 08803781)






CONTENTS OF THE ABBREVIATED ACCOUNTS
FOR THE PERIOD 5 DECEMBER 2013 TO 31 DECEMBER 2014




Page

Company Information 1

Abbreviated Balance Sheet 2

Notes to the Abbreviated Accounts 3

PHARMA IT CONSULTING LIMITED

COMPANY INFORMATION
FOR THE PERIOD 5 DECEMBER 2013 TO 31 DECEMBER 2014







DIRECTOR: P Marron





REGISTERED OFFICE: 2 Mill Road
Haverhill
Suffolk
CB9 8BD





REGISTERED NUMBER: 08803781 (England and Wales)





ACCOUNTANTS: Hackett Griffey LLP
Chartered Certified Accountants
2 Mill Road
Haverhill
Suffolk
CB9 8BD

PHARMA IT CONSULTING LIMITED (REGISTERED NUMBER: 08803781)

ABBREVIATED BALANCE SHEET
31 DECEMBER 2014

Notes £    £   
FIXED ASSETS
Tangible assets 2 1,880

CURRENT ASSETS
Debtors 19,647
Cash at bank 152
19,799
CREDITORS
Amounts falling due within one year 11,600
NET CURRENT ASSETS 8,199
TOTAL ASSETS LESS CURRENT
LIABILITIES

10,079

PROVISIONS FOR LIABILITIES 376
NET ASSETS 9,703

CAPITAL AND RESERVES
Called up share capital 3 1
Profit and loss account 9,702
SHAREHOLDERS' FUNDS 9,703

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 December 2014.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 December 2014 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.


The financial statements were approved by the director on 28 August 2015 and were signed by:





P Marron - Director


PHARMA IT CONSULTING LIMITED (REGISTERED NUMBER: 08803781)

NOTES TO THE ABBREVIATED ACCOUNTS
FOR THE PERIOD 5 DECEMBER 2013 TO 31 DECEMBER 2014

1. ACCOUNTING POLICIES

Accounting convention
The financial statements have been prepared under the historical cost convention and in accordance with the
Financial Reporting Standard for Smaller Entities (effective April 2008).

Turnover
Turnover is the amount derived from ordinary activities, stated after trade discounts, other sales taxes and net of
VAT.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Computer equipment - 25% on reducing balance

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance
sheet date.

2. TANGIBLE FIXED ASSETS
Total
£   
COST
Additions 2,227
At 31 December 2014 2,227
DEPRECIATION
Charge for period 347
At 31 December 2014 347
NET BOOK VALUE
At 31 December 2014 1,880

3. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal
value: £   
1 Ordinary £1 1

1 Ordinary share of £1 was allotted and fully paid for cash at par during the period.

4. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the period ended 31 December 2014:

£   
P Marron
Balance outstanding at start of period -
Amounts advanced 70,737
Amounts repaid (51,090 )
Balance outstanding at end of period 19,647

PHARMA IT CONSULTING LIMITED (REGISTERED NUMBER: 08803781)

NOTES TO THE ABBREVIATED ACCOUNTS - continued
FOR THE PERIOD 5 DECEMBER 2013 TO 31 DECEMBER 2014

4. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES - continued

Interest of £357 was charged on the above loan during the period at the rate of 4% / 3.25% p.a.